Elaeocarpus sylvestris var. ellipticus Extract and Its Major Component, Geraniin, Inhibit Herpes Simplex Virus-1 Replication

Yeong-Geun Lee,Dae Won Park,Jeong Eun Kwon,Hyunggun Kim,Se Chan Kang
DOI: https://doi.org/10.3390/plants13111437
2024-05-23
Plants
Abstract:Elaeocarpus sylvestris var. ellipticus (ES), which our research group had confirmed inhibits influenza A and SARS-CoV-2 viruses, was investigated to identify new potent and selective inhibitors of herpes simplex virus-1 (HSV–1) replication. To clarify the optimal condition for ES extract (ESE), ES was extracted at different concentrations of 0, 30, 50, 70, and 100%, to screen for its anti-HSV–1 effect. Among these ESE samples, ESE50 (50% concentration) exhibited the strongest inhibition of HSV–1 replication (EC50 23.2 μg/mL) while showing low cytotoxicity on host cells (IC50 342.8 μg/mL). The treatment of ESE50 clearly demonstrated a decrease in the expression of ICP0 in the lungs of HSV–1-infected BALB/c nude mice, compared to the MOCK group. Geraniin, which was isolated from ESE50 and analyzed using ESI−MS and 1D−(1H− and 13C−) and 2D−NMR, showed greater potency in inhibiting HSV–1 replication, as determined by the plaque reduction assay (EC50 8.3 μg/mL) and luciferase inhibition (EC50 36.9 μg/mL). The results demonstrate that ESE50 and geraniin show great potential as candidates for new drug discovery in the treatment of HSV–1 and related diseases.
plant sciences
What problem does this paper attempt to address?